首页 > Newsroom > Seizing Opportunities for Far-reaching Development | Sunrise Group Successfully Concludes CPHI Barcelona
Seizing Opportunities for Far-reaching Development | Sunrise Group Successfully Concludes CPHI Barcelona
From October 24th to 26th, CPHI Worldwide 2023, the prestigious international pharmaceutical ingredients exhibition, officially commenced at the Barcelona Exhibition Center in Spain. The event brought together industry leaders and global powerhouse companies, creating an invaluable platform for collaboration and innovation. The reunion after a long separation is truly precious.
Sunrise Group, together with Dachen Pharmaceutical as a distinguished chemical raw material distributor and pharmaceutical supplier, actively attended the exhibition. With unwavering enthusiasm, they welcomed global customers, providing professional supply solutions and service experiences, and jointly promoting high-quality development in the industry.
At the exhibition, products from the factories such as Aloe emodin and Sitagliptin intermediates garnered extensive attention and sparked insightful discussion. Recognizing the ongoing expansion of overseas markets and the evolving demands of customers, Sunrise is committed to intensifying its production layout of pharmaceutical intermediates and raw materials, thereby securing new avenues for growth.
The exhibition served as a hub for numerous overseas customers who visited the Sunrise booth, engaging in profound discussions on market trends, industry policies, and expressing intentions for future collaborations. The business team meticulously analyzed the emerging demands and issues of customers, providing optimized solutions and laying the foundation for enduring win-win partnerships.
Equipped with professional pharmaceutical ingredient solutions, Sunrise Group and Dachen Pharmaceutical will collaborate with partners in exploring further possibilities for communication, driving sustained and healthy development of the pharmaceutical industry, fostering innovation and progress.